Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
Plasmacytoid dendritic cells (pDCs) sense viral and microbial DNA through endosomal Toll-like receptors to produce type 1 interferons. pDCs do not normally respond to self-DNA, but this restriction seems to break down in human autoimmune disease by an as yet poorly understood mechanism. Here we identify the antimicrobial peptide LL37 (also known as CAMP) as the key factor that mediates pDC activation in psoriasis, a common autoimmune disease of the skin. LL37 converts inert self-DNA into a potent trigger of interferon production by binding the DNA to form aggregated and condensed structures that are delivered to and retained within early endocytic compartments in pDCs to trigger Toll-like receptor 9. Thus, our data uncover a fundamental role of an endogenous antimicrobial peptide in breaking innate tolerance to self-DNA and suggest that this pathway may drive autoimmunity in psoriasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the anti-microbial peptide LL37 has been shown to promote trafficking of aggregated DNA structures to the early endosome, promoting TLR9 activation and interferon production (Lande et al., 2007)”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Lande et al., 2007
In the citing paper
“Interestingly, suction blister wounds, where the blister roof is still intact, do not show substantial inflammation,9 whereas excisional wounds, ultraviolet (UV)-induced skin damage, superficial tape stripping or chemical skin irritants, and contact sensitizers cause inflammatory infiltrates,17,23–26”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [23]
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
IRF-7 is the master regulator of type-I interferon-dependent immune responses
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,245
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Self-citationEndogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960
Pathogenesis and therapy of psoriasis
Lowes, M. A., Bowcock, A. M., & Krueger, J. G. (2007) · Nature · doi:10.1038/nature05663 · Cited by 1,778
Plasmacytoid dendritic cells in immunity
Colonna, M., Trinchieri, G., & Liu, Y.-J. (2004) · Nature Immunology · doi:10.1038/ni1141 · Cited by 1,678
Self-citation
Cited by
Items 701–800 of 1,000
Han, J., Li, X., Luo, X., He, J., Huang, X., Zhou, Q., Han, Y., Jie, H., Zhuang, J., Li, Y., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110848 · Cited by 49
The Contribution of Antimicrobial Peptides to Immune Cell Function: A Review of Recent Advances
Li, H., Niu, J., Wang, X., Niu, M., & Liao, C. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092278 · Cited by 61
Sato, E., Imafuku, S., Chou, B., Ishii, K., Hiromatsu, K., & NAKAYAMA, J. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10917.x · Cited by 50
Neutrophil Extracellular Traps: A Walk on the Wild Side of Exercise Immunology
Beiter, T., Fragasso, A., Hartl, D., & Niess, A. M. (2014) · Sports Medicine · doi:10.1007/s40279-014-0296-1 · Cited by 54
Kanno, A., Yamamoto, C., Onji, M., Fukui, R., Saitoh, S.-I., Motoi, Y., Shibata, T., Matsumoto, F., Muta, T., & Miyake, K. (2013) · International Immunology · doi:10.1093/intimm/dxt007 · Cited by 48
Bossard, C., Malard, F., Arbez, J., Chevallier, P., Guillaume, T., Delaunay, J., Mosnier, J.-F., Tiberghien, P., Saas, P., Mohty, M., et al. (2012) · Leukemia · doi:10.1038/leu.2012.41 · Cited by 58
The Role of Extracellular DNA in Autoimmunity in SLE
Su, K., & Pisetsky, D. S. (2009) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2009.02300.x · Cited by 52
Treatment of Psoriasis and Psoriatic Arthritis
Papoutsaki, M., & Costanzo, A. (2013) · BioDrugs · doi:10.1007/bf03325637 · Cited by 49
Nucleic acid sensing by T cells initiates Th2 cell differentiation
Imanishi, T., Ishihara, C., Badr, M. E. S. G., Hashimoto, A. S., Kimura, Y., Kawai, T., Takeuchi, O., Ishii, K. J., Taniguchi, S., Noda, T., et al. (2014) · Nature Communications · doi:10.1038/ncomms4566 · Cited by 50
Antimicrobial Peptides, Infections and the Skin Barrier
Clausen, M., & Agner, T. (2016) · Current problems in dermatology · doi:10.1159/000441543 · Cited by 57
Korenfeld, D., Gorvel, L., Munk, A., Man, J. J., Schaffer, A., Tung, T., Mann, C. M., & Klechevsky, E. (2017) · JCI Insight · doi:10.1172/jci.insight.96101 · Cited by 50
Zeidi, M., Kim, H. J., & Werth, V. P. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.07.041 · Cited by 55
“Activation of intracellular TLRs by immune complexes formed by the antimicrobial peptides, such as cathelicidin and human β-defensin-2, and self-nucleic acids released by impaired clearance initiate autoimmune processes (Lande et al., 2007).”
BackgroundExtracellular vesicles in autoimmune vasculitis - Little dirts light the fire in blood vessels
Wu, X., Liu, Y., Wei, W., & Liu, M. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.12.007 · Cited by 51
Self-citationWilkinson, M. G. L., MOULDING, D. A., McDonnell, T. C. R., Orford, M., Wincup, C., Ting, J. Y. J., Otto, G., Restuadi, R., Kelberman, D., Papadopoulou, C., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223469 · Cited by 57
Morioka, Y., Yamasaki, K., Leung, D. Y. M., & Gallo, R. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3915 · Cited by 49
“Supporting this, and in contrast to the proposed model of cathelicidin-dependent TLR9 activation of plasmacytoid DCs in psoriasis, murine cathelcidin does not appear to be necessary for IFN production in the skin as no difference in IFN- production was seen Camp–/– mice compared with WT mice after trauma (M. Gilliet,…”
BackgroundInfluentialSustained Activation of Toll-Like Receptor 9 Induces an Invasive Phenotype in Lung Fibroblasts
Kirillov, V., Siler, J. T., Ramadass, M., Ge, L., Davis, J. E., Grant, G. M., Nathan, S. D., Járai, G., & Trujillo, G. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.12.011 · Cited by 52
Carvalho, A., Osório, N. S., Saraiva, M., Cunha, C., Almeida, A. J., Teixeira‐Coelho, M., Ludovico, P., Pedrosa, J., Pitzurra, L., Aversa, F., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028256 · Cited by 48
“In psoriasis, uncontrolled expression of the antimicrobial peptide LL37 breaks innate immune tolerance by delivering self-DNA to TLR9containing endosomes, causing TLR9-mediated type I interferon production that drives skin inflammation [3,11].”
BackgroundZhang, L., Jiang, Q., Li, G., Jeffrey, J., Kovalev, G. I., & Su, L. (2011) · Blood · doi:10.1182/blood-2011-01-331173 · Cited by 50
Takala, H., Kauppila, J. H., Soini, Y., Selander, K. S., Vuopala, K. S., Lehenkari, P. P., Saarnio, J., & Karttunen, T. J. (2011) · Journal of Innate Immunity · doi:10.1159/000329115 · Cited by 48
Holani, R., Babbar, A., Blyth, G. A. D., Lopes, F., Jijon, H. B., McKay, D. M., Hollenberg, M. D., & Cobo, E. R. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1785802 · Cited by 54
“The ability of cathelicidin to promote internalization of LPS was consistent with reports that cathelicidin aggregated with DNA, possibly due to the positive charges in the cathelicidin sequence, to promote internalization of DNA into endosomal compartments wherein it triggered TLR9 signaling.(70) However, LL-37 eithe…”
ResultAhmad, A., Azmi, S., Srivastava, R. M., Srivastava, S., Pandey, B., Saxena, R., Bajpai, V. K., & Ghosh, J. K. (2009) · Biochemistry · doi:10.1021/bi9009874 · Cited by 51
Psoriasis and Related Disorders
Burden, A. D., & Kirby, B. (2016) · Wiley eBooks · doi:10.1002/9781118441213.rtd0036 · Cited by 70
Zhang, M., Qin, X., Gao, Y., Liang, J., Xiao, D., Zhang, X., Zhou, M., & Lin, Y. (2023) · Advanced Science · doi:10.1002/advs.202303706 · Cited by 56
The Th17/IL-23 Axis and Natural Immunity in Psoriatic Arthritis
Maeda, S., Hayami, Y., Naniwa, T., & Ueda, R. (2012) · International Journal of Rheumatology · doi:10.1155/2012/539683 · Cited by 47
“It has been reported that LL37-mediated TLR9 signaling after aggregation with autogenous DNA and activation of pDCs resulted in the onset of psoriasis [68].”
BackgroundPlasmacytoid Dendritic Cells in Atherosclerosis
Döring, Y., & Zernecke, A. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00230 · Cited by 57
“While usually not recognizing self-nucleic acids, free self-DNA can be complexed to cationic LL-37 (or its murine homologue Cramp), a protein overexpressed and released by neutrophils as well as damaged epithelial cells in psoriasis (Lande et al., 2007).”
BackgroundStephan, A., Batinica, M., Steiger, J., Hartmann, P., Zaucke, F., Bloch, W., & Fabri, M. (2016) · Immunology · doi:10.1111/imm.12620 · Cited by 55
Elshikha, A. S., Lu, Y., Chen, M., Akbar, M. A., Zeumer, L., Ritter, A., Elghamry, H. A., Mahdi, M. A., Morel, L. M., & Song, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156583 · Cited by 47
“Endogenous DNA is recognized by TLR9 leading to activation of pDCs and production of type I interferon [20], which is believed to play a crucial role in SLE pathogenesis [21].”
BackgroundHolani, R., Shah, C., Haji, Q., Inglis, G. D., Uwiera, R. R. E., & Cobo, E. R. (2016) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2016.10.004 · Cited by 50
Re-evaluation of human BDCA-2+ DC during acute sterile skin inflammation
Chen, Y., Gomes, T., Hardman, C. S., Braga, F. A. V., Gutowska‐Owsiak, D., Salimi, M., Gray, N., Duncan, D. A., Reynolds, G., Johnson, D., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190811 · Cited by 52
“Notably, skin activated DCs expressed very high levels of CCL22, a chemoattractant for C-C chemokine receptor type 4 (CCR4)– expressing cells that facilitates migration into the skin (Elhussein Mohamed et al., 2016; Katou et al., 2001; Kusumoto et al., 2007; Layseca-Espinosa et al., 2013).”
BackgroundRioux, G., Ridha, Z., Simard, M., Turgeon, F., Guérin, S. L., & Pouliot, R. (2020) · Genes · doi:10.3390/genes11101155 · Cited by 50
“Moreover, Gilliet and his colleagues established that keratinocytes play a role in the initiation of psoriasis after injury by secreting the antimicrobial peptides LL-37 conjugated with self-DNA to activate toll-like receptor 9 in plasmacytoid dendritic cells [51].”
BackgroundSkin-Resident Memory T Cells: Pathogenesis and Implication for the Treatment of Psoriasis
Vu, T. T., Koguchi‐Yoshioka, H., & Watanabe, R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173822 · Cited by 54
“For example, cationic antimicrobial peptide LL-37 produced by various cells including keratinocytes binds self-DNA and triggers the activation of plasmacytoid dendritic cells (pDC) and TNF/iNOS-producing dendritic cells (TIP-DC) [81,82].”
BackgroundYang, C., Bachu, M., Du, Y., Brauner, C., Yuan, R., Kioon, M. D. A., Chesi, G., Barrat, F. J., & Ivashkiv, L. B. (2022) · Nature Communications · doi:10.1038/s41467-022-31132-7 · Cited by 55
Karrich, J. J., Jachimowski, L. C. M., Uíttenbogaart, C. H., & Blom, B. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401541 · Cited by 54
“LL37 complexes with self-DNA/RNA released by dying cells and engages TLR7/9, leading to chronic IFN-a production (112, 113).”
BackgroundKienhöfer, D., Hahn, J., Schubert, I., Reinwald, C., Ipseiz, N., Lang, S. C., Borràs, È. B., Amann, K., Sjöwall, C., Barron, A. E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115474 · Cited by 48
“E). doi:10.1371/journal.pone.0115474.g003 PLOS ONE | DOI:10.1371/journal.pone.0115474 December 23, 2014 9 / 19 Functional implications of CRAMP for lupus pathogenesis The effect LL-37 can have on SLE pathogenesis has been attributed to two modes of action: firstly, LL-37 has been shown to form ionic complexes with nuc…”
BackgroundMethodInfluentialHoffmann, M. H., Skriner, K., Herman, S., Baumann, C., Steiner, C.-W., Ospelt, C., Meyer, B., Gleiß, A., Pfatschbacher, J., Niederreiter, B., et al. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.02.007 · Cited by 46
“While there is already ample evidence about a direct involvement of these nucleic acids in lupus [23,30e33] and psoriasis [34,35], their role has not been fully elucidated in inflammatory arthritis yet.”
BackgroundSerum Levels of LL-37 and Inflammatory Cytokines in Plaque and Guttate Psoriasis
Hwang, Y. J., Jung, H. J., Kim, M. J., Roh, N. K., Jung, J. W., Lee, Y. W., Choe, Y. B., & Ahn, K. J. (2014) · Mediators of Inflammation · doi:10.1155/2014/268257 · Cited by 54
Two, A. M., Hata, T. R., Nakatsuji, T., Coda, A. B., Kotol, P. F., Wu, W., Shafiq, F., Huang, E. Y., & Gallo, R. L. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.472 · Cited by 46
Psoriasis as Autoinflammatory Disease
Bejarano, J. J. R., & Valdecantos, W. C. (2013) · Dermatologic Clinics · doi:10.1016/j.det.2013.04.009 · Cited by 45
Hepatitis C may enhance key amplifiers of psoriasis
Chun, K., Afshar, M., Audish, D., Kabigting, F. D., Paik, A. J., Gallo, R. L., & Hata, T. R. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13578 · Cited by 48
Interleukin 23 and autoimmune diseases: current and possible future therapies
Abdo, A. I. K., & Tye, G. J. (2020) · Inflammation Research · doi:10.1007/s00011-020-01339-9 · Cited by 47
“Studies by Lande and Ganguly [45, 46] demonstrated that LL-37, a human endogenous AMP secreted by stressed or injured KCs, is able to bind to selfDNA or RNA released from dying cells.”
BackgroundPsoriasis immunometabolism: progress on metabolic biomarkers and targeted therapy
Sarandi, E., Krueger‐Krasagakis, S. E., Tsoukalas, D., Sidiropoulou, P., Evangelou, G., Sifaki, M., Rudofsky, G., Drakoulis, N., & Tsatsakis, A. M. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1201912 · Cited by 241
“Keratinocytes are appreciated as initiators of the immune response through the production of autoantigens and in the establishment of the disease through the crosstalk with adaptive immunity cells that aggravates the cytokine milieu and intensifies chronic inflammation (Lande et al., 2007; Hawkes et al., 2017; Zhou et…”
BackgroundLL-37 expression in the skin in systemic lupus erythematosus
Sun, C.-L., Zhang, F., Li, P., & Lq, B. (2011) · Lupus · doi:10.1177/0961203311398515 · Cited by 46
Toll‐like receptors in rheumatic diseases: Are we paying a high price for our defense against bugs?
Santegoets, K. C. M., van Bon, L. G., van den Berg, W. B., Wenink, M. H., & Radstake, T. R. D. J. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.028 · Cited by 52
Human β‐defensin 3 increases the TLR9‐dependent response to bacterial DNA
McGlasson, S. L., Semple, F., Macpherson, H. K., Gray, M., Davidson, D. J., & Dorin, J. R. (2017) · European Journal of Immunology · doi:10.1002/eji.201646799 · Cited by 45
Vitamin D Regulation of Cathelicidin in the Skin: Toward a Renaissance of Vitamin D in Dermatology?
Segaert, S. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.35 · Cited by 45
Mechanisms of vascular damage in ANCA vasculitis
Massicotte‐Azarniouch, D., Herrera, C. A., Jennette, J. C., Falk, R. J., & Free, M. E. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00920-0 · Cited by 52
“Exteriorized DNA with LL37 from NETs trigger selfrecognition of DNA by dendritic cells in other autoimmune conditions such as psoriasis [31].”
BackgroundNeutrophil extracellular traps in acute coronary syndrome
Wu, Y., Wei, S., Wu, X., Li, Y., & Han, X. (2023) · Journal of Inflammation · doi:10.1186/s12950-023-00344-z · Cited by 49
“In addition, NETs can also form autoantigens that induce certain diseases, for example, in systemic lupus erythematosus (SLE), NETs can activate plasmacytoid dendritic cells (pDCs) and trigger type I interferon (IFN) production and drive autoimmune pathology [54, 55].”
BackgroundFarkas, Á., & Kemény, L. V. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.04.003 · Cited by 44
“In psoriasis, however self-DNA and self-RNA form complexes with the antimicrobial peptide LL37; these complexes, which are protected from extracellular degradation are transported into endosomal compartments of pDCs, where they trigger the production of IFN-α through the activation of TLR9 and TLR7 respectively [13,17…”
BackgroundNardo, A. D., Holmes, A. D., Muto, Y., Huang, E. Y., Preston, N. J., Winkelman, W. J., & Gallo, R. L. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.01.023 · Cited by 49
Prognostic impact of high levels of circulating plasmacytoid dendritic cells in breast cancer
Bailur, J. K., Gueckel, B., & Pawelec, G. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0905-x · Cited by 48
Johansen, C., Rittig, A. H., Mose, M., Bertelsen, T., Weimar, I., Nielsen, J., Andersen, T., Rasmussen, T. K., Deleuran, B. W., & Iversen, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176994 · Cited by 47
Lorthois, I., Asselineau, D., Seyler, N., & Pouliot, R. (2017) · Mediators of Inflammation · doi:10.1155/2017/7215072 · Cited by 44
“These antimicrobial peptides can stimulate immune cell infiltration, and NET-derived DNA-LL37 nucleic acid complexes promoted IFN-α secretion of plasmacytoid dendritic cells [21].”
Backgroundvan Dam, L. S., Rabelink, T. J., van Kooten, C., & Teng, Y. K. O. (2018) · Kidney International Reports · doi:10.1016/j.ekir.2018.11.005 · Cited by 50
“NETs are believed to be an important source of autoantigens in systemic autoimmune diseases.(12,21,24,25,30,39) 48 Indeed, 74% of these identified NET-associated proteins are recognized by autoantibodies in systemic autoimmune diseases.”
BackgroundDNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells
Tuomela, J. M., Sandholm, J. A., Kaakinen, M., Patel, A. K., Kauppila, J. H., Ilvesaro, J. M., Chen, D., Harris, K. W., Graves, D. E., & Selander, K. S. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2762-0 · Cited by 45
“Since LL-37 has been shown to promote DNA uptake and mediate endogenous DNA effects on TLR9 in non-cancerous cells, we also investigated the role of LL-37 in these processes in cancer cells [15, 16].”
Copy-number analysis goes more than skin deep
McCarroll, S. A. (2007) · Nature Genetics · doi:10.1038/ng0108-5 · Cited by 49
Early immunologic changes during the onset of atopic dermatitis
Brunner, P. M. (2019) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2019.03.033 · Cited by 42
Chemokines form nanoparticles with DNA and can superinduce TLR-driven immune inflammation
Du, Y., Kioon, M. D. A., Laurent, P., Chaudhary, V., Pierides, M., Yang, C., Oliver, D., Ivashkiv, L. B., & Barrat, F. J. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20212142 · Cited by 50
Increased LL37 in psoriasis and other inflammatory disorders promotes LDL uptake and atherosclerosis
Nakamura, Y., Kulkarni, N. N., Takahashi, T., Alimohamadi, H., Dokoshi, T., Liu, E., Shia, M., Numata, T., Luo, E. W.-C., Gombart, A. F., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci172578 · Cited by 48
“LL37 promotes entry of nucleic acids such as U1-RNA into the cytosol via scavenger receptors (17, 18, 34, 35).”
Endogenous Intracellular Cathelicidin Enhances TLR9 Activation in Dendritic Cells and Macrophages
Nakagawa, Y., & Gallo, R. L. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1402388 · Cited by 44
“Previous reports have shown that the combination of LL-37 and DNA enhanced the TLR9 response (17).”
BackgroundInfluentialJönsson, D., & Nilsson, B. (2011) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2011.01436.x · Cited by 43
Molecular Characterization of Human Plasmacytoid Dendritic Cells
Cao, W. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9284-x · Cited by 51
“Because intracellular TLRs have a limited ability to discriminate between nucleic acids originating from the host and those that are foreign [16], additional mechanisms are essential to prevent the spontaneous activation of pDCs by endogenous nucleic acids and subsequent production of IFN-I, which has been directly im…”
BackgroundSelf-citationTargeting the IL17 Pathway for the Prevention of Graft-Versus-Host Disease
van der Waart, A. B., van der Velden, W. J. F. M., Blijlevens, N. M. A., & Dolstra, H. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.02.007 · Cited by 47
Bracke, S., Desmet, E., Guerrero‐Aspizua, S., Tjabringa, S., Schalkwijk, J., Gele, M. V., Carretero, M., & Lambert, J. (2013) · Archives of Dermatological Research · doi:10.1007/s00403-013-1379-9 · Cited by 47
“opment of psoriasis, the cathelicidin antimicrobial peptide LL37 has shown to bind to self-DNA fragments released by ‘stressed’ or dying KCs [24].”
BackgroundPathogen sensors and chemokine receptors in dendritic cell subsets
Kaisho, T. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.043 · Cited by 46
Microparticles as autoadjuvants in the pathogenesis of SLE
Pisetsky, D. S., & Lipsky, P. E. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.66 · Cited by 49
“Importantly, in vitro and in vivo studies have demonstrated that nucleic acids are potent immune stimulants and that their incorporation into protein complexes or lipid vesicles can enhance their activity and trigger multiple signaling cascades”
BackgroundChen, S., de Groot, M., Kinsley, D., Laverty, M., McClanahan, T. K., Arreaza, M. G., Gustafson, E. L., Teunissen, M. B. M., de Rie, M. A., Fine, J. S., et al. (2009) · Archives of Dermatological Research · doi:10.1007/s00403-009-0966-2 · Cited by 42
“Very recently, a report demonstrated a unique pathway of pDC activation and its induction to secrete high levels of IFN- by the binding of self-DNA in complex with an antimicrobial peptide LL37 over expressed in psoriatic skin [ 26 ].”
BackgroundHau, C. S., Kanda, N., Noda, S., Tatsuta, A., Kamata, M., Shibata, S., Asano, Y., Sato, S., Watanabe, S., & Tada, Y. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.044 · Cited by 44
“Infectious or traumatic stimuli induce the release of LL-37 from keratinocytes.(3,10) LL-37 combines”
BackgroundLifting the Silver Flakes: The Pathogenesis and Management of Chronic Plaque Psoriasis
Chong, H. T., Kopecki, Z., & Cowin, A. J. (2013) · BioMed Research International · doi:10.1155/2013/168321 · Cited by 43
“Plasmacytoid DCs express TLR (Toll-like receptor) 9 and produce IFN-α when activated with the antimicrobial cathelicidin LL37 bound to self-DNA fragments released by injured cells in the skin [5, 17].”
BackgroundTh17 micro-milieu regulates NLRP1-dependent caspase-5 activity in skin autoinflammation
Zwicker, S., Hattinger, E., Bureik, D., Batycka-Baran, A., Schmidt, A., Gerber, P. A., Rothenfußer, S., Gilliet, M. F., Ruzicka, T., & Wolf, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175153 · Cited by 46
Self-citationFischer, H., Buchberger, M., Napirei, M., Tschachler, E., & Eckhart, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-06652-8 · Cited by 50
Decreased A-to-I RNA editing as a source of keratinocytes' dsRNA in psoriasis
Shallev, L., Kopel, E., Feiglin, A., Leichner, G. S., Avni, D., Sidi, Y., Eisenberg, E., Barzilai, A., Levanon, E. Y., & Greenberger, S. (2018) · RNA · doi:10.1261/rna.064659.117 · Cited by 45
“Subsequently, the complexes are recognized by TLRs, leading to IFN production (Lande et al. 2007; Ganguly et al. 2009).”
BackgroundToll-Like Receptors and Type 1 Diabetes
Zipris, D. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_25 · Cited by 51
“For example, DCs were linked with cardiomyopathy [77, 78], systemic lupus erythematosus [79], and psoriasis [80].”
BackgroundThe role of circulating cell-free DNA as an inflammatory mediator after stroke
Roth, S., Wernsdorf, S. R., & Liesz, A. (2023) · Seminars in Immunopathology · doi:10.1007/s00281-023-00993-5 · Cited by 45
“LL37 is described to increase the immunogenicity of extracellular DNA into a potent ligand driving a TLR9-dependent IFN response [70].”
BackgroundNatural Killer Cells in Psoriasis
Tobin, A., Lynch, L., Kirby, B., & O’Farrelly, C. (2011) · Journal of Innate Immunity · doi:10.1159/000328011 · Cited by 44
Toll-Like Receptor 9 in Breast Cancer
Sandholm, J. A., & Selander, K. S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00330 · Cited by 47
“Self-DNA has been shown to have TLR9-mediated inflammatory effects in other cell types, especially when complexed with LL-37, which is expressed in various tissues (16, 48, 52, 62).”
BackgroundCytokines as therapeutic targets in skin inflammation
Wittmann, M., McGonagle, D., & Werfel, T. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.008 · Cited by 46
“[60] and others put the concept forward that LL37–DNA complexes induce the production of type I IFNs by pDC which may be of significance for psoriasis and lupus”
BackgroundChasset, F., Dayer, J., & Chizzolini, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.633821 · Cited by 46
“A more recently described mechanism shown to favor the production of IFN-I by pDC involves the capacity of amphipathic peptides to form complexes with extracellular DNA or RNA allowing the shuttling of this material into endosomes (Lande et al., 2007; Ganguly et al., 2009; Lande et al., 2019).”
BackgroundMurata, H., Kinoshita, M., Yasumizu, Y., Motooka, D., Beppu, S., Shiraishi, N., Sugiyama, Y., Kihara, K., Tada, S., Koda, T., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001149 · Cited by 44
“cfDNA of Patients With NMOSD Induces IFN-1 Production in the Presence of LL37 It is known that nuclear-derived self-DNA is not taken up by DCs without the presence of cofactors such as antimicrobial peptides.(20,21) To further clarify the mechanism by which cfDNA induces the production of IFN-1, we examined the amount…”
BackgroundInfluentialDendritic cells – why can they help and hurt us
Schäkel, K. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00823.x · Cited by 46
Okuya, K., Tamura, Y., Saito, K., Kutomi, G., Torigoe, T., Hirata, K., & Sato, N. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000490 · Cited by 42
“Previous studies revealed that CpG-A or various DNAs needed to be retained for long periods in the endosomes of pDCs for sufficient activation of TLR9 signaling (25, 26).”
BackgroundToll-like receptor 7 stimulation promotes autoimmune diabetes in the NOD mouse
Lee, A., Ghoreishi, M., Cheng, W. K., Chang, T.-Y. E., Zhang, Y. Q., & Dutz, J. P. (2011) · Diabetologia · doi:10.1007/s00125-011-2083-y · Cited by 43
“Endosomal TLRs (TLR3, 7, 8 and 9) recognise RNA or DNA oligonucleotides and have been linked to the development of autoimmune disorders such as systemic lupus erythematosus, rheumatoid arthritis [12, 13] and psoriasis [14].”
Control of cutaneous antimicrobial peptides by vitamin D3
Dombrowski, Y., Perić, M., Koglin, S., Ruzicka, T., & Schauber, J. (2010) · Archives of Dermatological Research · doi:10.1007/s00403-010-1045-4 · Cited by 41
“Thus, in psoriasis overexpression of cathelicidin together with a second factor (self-DNA) which under healthy conditions is not present in the skin might lead to skin inXammation [ 41 ].”
BackgroundInfluentialNational Survey of Psoriasis Flares after 2009 Monovalent H1N1/Seasonal Vaccines
Sbidian, É., Eftekahri, P., Viguier, M. A., Laroche, L., Chosidow, O., Gosselin, P., Trouche, F., Bonnet, N., Arfi, C., Tubach, F., et al. (2014) · Dermatology · doi:10.1159/000362808 · Cited by 41
TLR Signaling and DNA Repair: Are They Associated?
Harberts, E. M., & Gaspari, A. A. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.288 · Cited by 41
“The antimicrobial peptide LL37 has also been shown to complex with free self nucleic acids and serve as a TLR 7 and 8 agonist (Ganguly et al., 2009; Lande et al., 2007).”
BackgroundThomas‐Virnig, C. L., Centanni, J. M., Johnston, C. E., He, L., Schlosser, S. J., Winkle, K. F. V., Chen, R., Gibson, A. L. F., Szilágyi, A., Li, L., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2008.289 · Cited by 42
DNA Transfer and Toll-like Receptor Modulation by Helicobacter pylori
Varga, M. G., & Peek, R. M. (2017) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-50520-6_8 · Cited by 44
“Granulin, HMGB1, and LL-37 have all been implicated as a DNA binding proteins that may facilitate DNA delivery to TLR9 (Lande et al. 2007; Tian et al. 2007; Yanai et al. 2009; Park et al. 2011).”
BackgroundHuman and Murine Evidence for Mechanisms Driving Autoimmune Photosensitivity
Wolf, S., Estadt, S. N., Gudjonsson, J. E., & Kahlenberg, J. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02430 · Cited by 49
Metabolic Syndrome and psoriatic arthritis: considerations for the clinician
Caso, F., Chimenti, M. S., Navarini, L., Ruscitti, P., Peluso, R., Girolimetto, N., PUENTE, A. D., Giacomelli, R., Scarpa, R., & Costa, L. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1740593 · Cited by 44
Antibiotics: A Bibliometric Analysis of Top 100 Classics
Arshad, A. I., Ahmad, P., Karobari, M. I., Asıf, J. A., Alam, M. K., Mahmood, Z., Rahman, N. A., Mamat, N., & Kamal, M. A. (2020) · Antibiotics · doi:10.3390/antibiotics9050219 · Cited by 48
“[95] 1998 50 35 1099 1119 1597 75 Harder et al.”
Breakthrough concepts in immune-oncology: Cancer vaccines at the bedside
Roy, S., Sethi, T. K., Taylor, D., Kim, Y. J., & Johnson, D. B. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.5bt0420-585rr · Cited by 49
Antimicrobial peptides: bridging innate and adaptive immunity in the pathogenesis of psoriasis
Ma, J., Shao, S., & Wang, G. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001240 · Cited by 45
The RNase MCPIP3 promotes skin inflammation by orchestrating myeloid cytokine response
Liu, B., Huang, J., Ashraf, A., Rahaman, O., Lou, J., Wang, L., Cai, P., Wen, J., Anwaar, S., Liu, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24352-w · Cited by 43
“R el at iv e ex pr es si on Nfkbiz 3' UTR (1-1294) MΦ”
BackgroundMelanoma and innate immunity – Active inflammation or just erroneous attraction?
Navarini, A. A., & Conrad, C. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.10.012 · Cited by 49
Hsiao, H.-B., Chou, A.-H., Lin, S.-I., Chen, I.-H., Lien, S.-P., Liu, C.-C., Chong, P., & Liu, S.-J. (2014) · Journal of Virology · doi:10.1128/jvi.00867-14 · Cited by 41
The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma
Carvalho, A., Cunha, C., Almeida, A. J., Osório, N. S., Saraiva, M., Teixeira‐Coelho, M., Pedreiro, S., Torrado, E., Domingues, N. L. C., Gomes‐Alves, A. G., et al. (2011) · Genes and Immunity · doi:10.1038/gene.2011.59 · Cited by 45
The sweetness of the DNA backbone drives Toll-like receptor 9
Wagner, H. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.06.013 · Cited by 41
The antimicrobial peptide cathelicidin enhances activation of lung epithelial cells by LPS
Shaykhiev, R., Sierigk, J., Herr, C., Krasteva‐Christ, G., Kummer, W., & Bals, R. (2010) · The FASEB Journal · doi:10.1096/fj.09-151332 · Cited by 45
Peptidylarginine deiminases 4 as a promising target in drug discovery
Yang, C., Dong, Z., Jing, Z., Teng, D., Luo, X., Li, D., & Zhou, Y. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113840 · Cited by 45
The Role of the Neutrophilic Network in the Pathogenesis of Psoriasis
Czerwińśka, J., & Owczarczyk-Saczonek, A. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031840 · Cited by 46
“LL-37/DNA complex (resistant to degradation by nuclease) is detected by pDCs [37,50,51] and then transported to the endosome where it activates the toll-like receptor TLR9 [51,52] and cytosolic GAS/STING receptors [30,53].”
BackgroundAccumulation of plasmacytoid DC: Roles in disease pathogenesis and targets for immunotherapy
Swiecki, M. K., & Colonna, M. (2010) · European Journal of Immunology · doi:10.1002/eji.201040602 · Cited by 41
Metadata
- Authors
- Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., Zal, T., Mellman, I., Schröder, J.-M., Liu, Y.-J., & Gilliet, M.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Genentech (US)
- Heinrich Heine University Düsseldorf (DE)
- King's College London (GB)
- Christian-Albrechts-Universität zu Kiel (DE)
- Corresponding author
- Gilliet, Michel
- ORCID
- Venue
- Nature
- Published
- 2007-09-16
- Volume
- 449
- Issue
- 7162
- Pages
- 564-569
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2084951281
- Cited by
- 1,910
- References
- 43
- Citations by year
- 2026: 54 · 2025: 61 · 2024: 87 · 2023: 81 · 2022: 94 · 2021: 93 · 2020: 89 · 2019: 97 · 2018: 92 · 2017: 118 · 2016: 105 · 2015: 81 · 2014: 113 · 2013: 120 · 2012: 181
- FWCI
- 38.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI074809)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- plasmacytoid dendritic cells, LL-37, antimicrobial peptides, self-DNA, TLR9, type I interferon, psoriasis, autoimmunity, innate immune tolerance, vaccine adjuvants, skin inflammation
- MeSH terms
- Autoantigens, Autoimmune Diseases, Dendritic Cells, DNA, Endocytosis, Humans, Psoriasis, Endosomes, Autoimmunity, Antimicrobial Cationic Peptides, Toll-Like Receptor 9, Cathelicidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.